Sign in

NCT07367880Recruiting

The Monument Test : A New Tool for Assessing the Ability to Name and Identify Unique Entities. (TeDIMO)

Source: ClinicalTrials.gov · Last updated 26 May 2026

Brief summary (registry, in English)

The goal of this study is to show a significant difference in performance between 2 groups of participants (healthy elderly people vs. people with Alzheimer Disease) in an identification and naming task involving famous monuments.

Status (registry)
Recruiting
Study type
Observational
Enrollment
220 (estimated)
First submitted
15 Dec 2025
Start date
23 Feb 2026
Primary completion date
1 Feb 2031
Lead sponsor
University Hospital, Grenoble
NCT number
NCT07367880

What you commit to

  • Study type: Observational
  • Planned participants: 220
  • From 23 Feb 2026 to the primary completion date, 1 Feb 2031
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Alzheimer's disease:
    • Persons referred to in Articles L1121-5 to L1121-8 of the CSP
  • Controls:
    • Memory complaints
    • Persons referred to in Articles L1121-5 to L1121-8 of the CSP For all subjects
    • Significant neurological or psychiatric history
    • Taking psychotropic medication (neuroleptics)
    • Poor command of the French language, comprehension difficulties
    • Significant hearing or visual impairments (diplopia, nystagmus, scotoma, etc.)
    • Insufficient exposure to the media and/or socio-cultural knowledge (questionnaire) ; Deficit in face recognition (Benton Face Recognition Test)

Who the study is looking for

  • Alzheimer's disease:
    • Age ≥ 50 years and older
    • Possible or probable diagnosis of Alzheimer's disease according to the revised criteria of Mac Khann et al., 2011.
    • Score 18≤ MMSE ≤26
  • Controls:
    • Age ≥ 50 years and older
    • MMSE score ≥ 26 For all subjects
    • No objection from the participant

Age in the registry: 50 years to 95 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
CHU Grenoble Alpes
Coordinator of this site? Confirm its status
GrenobleFranceRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.